deltatrials
Completed PHASE2 NCT00160342

Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes

A Multi-Center, Double-Blind, Placebo-Controlled Comparison of Multiple Doses of Esterified Estrogens and Methyltestosterone, in Combination and Alone, in Relieving Vasomotor Symptoms in Postmenopausal Women

Sponsor: Solvay Pharmaceuticals

Conditions Hot Flushes, Menopause, Postmenopause
Interventions Esterified Estrogens (EE) and Methyltestosterone (MT)
Updated 7 times since 2017 Last updated: Aug 14, 2008 Started: Jun 30, 2005 Primary completion: Sep 30, 2007 Completion: Sep 30, 2007

A PHASE2 clinical study on Hot Flushes, Menopause, Postmenopause, this trial is completed. The trial is conducted by Solvay Pharmaceuticals and has accumulated 7 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Jun 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Solvay Pharmaceuticals
Data source: Solvay Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abbotsford, Canada, Alpharetta, United States, Ann Arbor, United States, Atlanta, United States, Aventura, United States, Baton Rouge, United States, Billings, United States, Boise, United States, Bryan, United States, Burlington, Canada and 85 more location s